160 related articles for article (PubMed ID: 16454739)
1. Receptor-independent effects of endocannabinoids on ion channels.
Oz M
Curr Pharm Des; 2006; 12(2):227-39. PubMed ID: 16454739
[TBL] [Abstract][Full Text] [Related]
2. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids.
Oz M
Pharmacol Ther; 2006 Jul; 111(1):114-44. PubMed ID: 16584786
[TBL] [Abstract][Full Text] [Related]
3. Actions and Regulation of Ionotropic Cannabinoid Receptors.
De Petrocellis L; Nabissi M; Santoni G; Ligresti A
Adv Pharmacol; 2017; 80():249-289. PubMed ID: 28826537
[TBL] [Abstract][Full Text] [Related]
4. Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors.
Oz M; Al Kury L; Keun-Hang SY; Mahgoub M; Galadari S
Eur J Pharmacol; 2014 May; 731():100-5. PubMed ID: 24642359
[TBL] [Abstract][Full Text] [Related]
5. Anandamide as an intracellular messenger regulating ion channel activity.
van der Stelt M; Di Marzo V
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):111-22. PubMed ID: 16099396
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.
Barana A; Amorós I; Caballero R; Gómez R; Osuna L; Lillo MP; Blázquez C; Guzmán M; Delpón E; Tamargo J
Cardiovasc Res; 2010 Jan; 85(1):56-67. PubMed ID: 19689982
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.
Amorós I; Barana A; Caballero R; Gómez R; Osuna L; Lillo MP; Tamargo J; Delpón E
J Mol Cell Cardiol; 2010 Jan; 48(1):201-10. PubMed ID: 19616555
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the Cys-loop ligand-gated ion channels by fatty acid and cannabinoids.
Zhang L; Xiong W
Vitam Horm; 2009; 81():315-35. PubMed ID: 19647117
[TBL] [Abstract][Full Text] [Related]
9. Phytocannabinoids and endocannabinoids.
Fisar Z
Curr Drug Abuse Rev; 2009 Jan; 2(1):51-75. PubMed ID: 19630737
[TBL] [Abstract][Full Text] [Related]
10. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
Pertwee RG; Howlett AC; Abood ME; Alexander SP; Di Marzo V; Elphick MR; Greasley PJ; Hansen HS; Kunos G; Mackie K; Mechoulam R; Ross RA
Pharmacol Rev; 2010 Dec; 62(4):588-631. PubMed ID: 21079038
[TBL] [Abstract][Full Text] [Related]
11. Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids.
De Petrocellis L; Starowicz K; Moriello AS; Vivese M; Orlando P; Di Marzo V
Exp Cell Res; 2007 May; 313(9):1911-20. PubMed ID: 17428469
[TBL] [Abstract][Full Text] [Related]
12. Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects.
Lozovaya N; Min R; Tsintsadze V; Burnashev N
Cell Calcium; 2009 Sep; 46(3):154-62. PubMed ID: 19682741
[TBL] [Abstract][Full Text] [Related]
13. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
14. Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids.
Lam PM; McDonald J; Lambert DG
Br J Anaesth; 2005 May; 94(5):649-56. PubMed ID: 15722382
[TBL] [Abstract][Full Text] [Related]
15. CB receptor ligands from plants.
Woelkart K; Salo-Ahen OM; Bauer R
Curr Top Med Chem; 2008; 8(3):173-86. PubMed ID: 18289087
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
Di Marzo V; Melck D; Bisogno T; De Petrocellis L
Trends Neurosci; 1998 Dec; 21(12):521-8. PubMed ID: 9881850
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons.
Stumpf A; Parthier D; Sammons RP; Stempel AV; Breustedt J; Rost BR; Schmitz D
Neuropharmacology; 2018 Sep; 139():217-225. PubMed ID: 30025920
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
19. Alcohols and neurotransmitter gated ion channels: past, present and future.
Lovinger DM
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):267-82. PubMed ID: 9303562
[TBL] [Abstract][Full Text] [Related]
20. Ligands for cannabinoid receptors, promising anticancer agents.
Nikan M; Nabavi SM; Manayi A
Life Sci; 2016 Feb; 146():124-30. PubMed ID: 26764235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
